Infrastructure Developments in China: Ken Research

Ken Research has announced its distribution on, “Infrastructure Insight: China” which provides a detailed view into the infrastructure sector in China, including analysis of the state of the current infrastructure, the regulatory and financing landscapes and the major projects in the construction pipeline.

The report describes all key infrastructure sectors: roads, railways, electricity and power, water and sewerage, communication, and airports and ports along with a brief analysis of the administrative, economic and political context for infrastructure in China.

It furnishes an explanation of the key drivers of growth in new investment and an overview of the project pipeline, with a detailed look at the prospects for major projects and the companies that have secured contract.

Report makes it easier to assess the current state of Chinese infrastructure and the main drivers of investment, including the key institutions and financing methods and further investigate forecasts and gain a comprehension of key trends in each of the main infrastructure sectors.

Key Market Dynamics

• Infrastructure developmentpersists to be a top priority for China’s government, which has long realized that a modern economy runs on reliable roads and rails, electricity, and telecommunications.
• From the late 1990s to 2005, 100 million Chinese profited from power and telecommunications upgrades. Between 2001 and 2004, investment in rural roads propagated by a massive 51 percent annually. And in recent years, the government is using substantial infrastructure spending to hedge against flagging economic growth.
• While China's overall economic expansion had been constantly falling, investors remained positive considering it to be an outcome of the nation developing, with a dwindling productivity gap compared with advanced economies leading to a natural downfall in growth as it becomes more difficult to close.
• China's 13th Five Year Plan (2016-2020) forms the country's most recent set of social and economic initiatives, including priorities for its infrastructure sectors. Among the infrastructure targets are investments of USD 395 billion in road and rail. Renewable and sustainable infrastructure has become more of a priority, especially in the areas of water, sewerage, electricity and power.
• China’s leadership has mapped equally ambitious plans for the future. Infrastructure is likely to continue to be a prestigious part of the Chinese investment program. Its goal is to bring the whole nation’s urban infrastructure up to the level of infrastructure in a middle-income country, using increasingly efficient transport logistics to tie the country together. As a result, the Chinese construction industry outpaced GDP growth in 2016.
• Moreover, the country restated its dedication to infrastructure spending in the immediate term, quoting low raw material prices and increasing domestic demand as construction drivers.
• 1,455 large-scale infrastructure construction projects are currently being recorded in China with a total investment value of USD 2.8 trillion.
• The railways sector accounts for the largest share of the project, with a total value of USD 1.25 trillion.
• The public sector is expected to directly fund 79% of the infrastructure construction project pipeline, with a further 13% being funded privately; the remaining 8% will be funded through public-private partners and this proportion of government-funded projects is forecasted to become a greater concern in the future, as government debt will reach new heights and China will accordingly adjust to growth levels though at a slow pace.

Key Factors Considered in the Report

China Infrastructure Industry research report

China Road Construction Sector

Rail Construction Industry China

Electricity and Power Infrastructure Sector

China Infrastructure Construction future Outlook

China Construction Industry Investments

China Road Construction by Value

Railways Construction Projects in China

For more coverage click on the link below:

https://www.kenresearch.com/manufacturing-and-construction/infrastructure/infrastructure-insight-china/81986-97.html

Related links:

https://www.kenresearch.com/manufacturing-and-construction/infrastructure/infrastructure-insight-uk/44254-97.html

https://www.kenresearch.com/manufacturing-and-construction/infrastructure/infrastructure-insight-australia/46017-97.html

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
Ankur@kenresearch.com
+91-9015378249

Social Housing Driving Portugal Residential Construction Market: Ken Research

Ken Research has announced publication titled, “Residential Construction in Portugal to 2020: Market Forecast” which provides detailed historic and forecast market value data for the residential construction industry, including a breakdown of the data by construction activity (new construction, repair and maintenance, refurbishment and demolition).
The report includes historical and forecast valuations of the industry using the construction output and value added methods. It is an important tool for companies active across the Portuguese construction value chain and for new players who consider entering the market and includes all the valuable data required by the users.

Study is the result of substantial market research covering the infrastructure construction industry in Portugal and furnishes a top-level overview and detailed insight into the operating environment of the infrastructure construction industry in Portugal.
The residential construction industry is composed of businesses principally involved in new residential construction and remodeling of single-family and multifamily residential buildings.
This industry includes residential housing general contractors (i.e., new construction, remodeling, or renovating existing residential structures), operative builders and remodelers of residential structures, residential project construction management firms, and residential design-build firms. Even, Specialty Trade Contractors perform specialized construction work (masonry, metal working, drywall) on houses and other residential buildings in some cases.
Over two thirds of all Portuguese property is owned by Portugal inhabitants that exceed 10 million in total and enough housing buildings are being constructed and more further are to be constructed to meet the needs of Portuguese well keeping in consideration all the regulations that govern the market.
In 2015, the government inaugurated O programa Reabilitar para Arrendar – Habitacao Acessivel, a rental rehabilitation program, with an investment of USD 55.5 million. The government is going to provide financial assistance to both public and private developers with an aim to increase the number of affordable houses in the country in the years to proceed.
The government’s focus on providing affordable houses via social housing programs is forecasted to lead optimal growth in the residential construction market over the forecast period.
The residential market is forecasted to prosper at an improved CAGR year by year as can be seen from the current level of amelioration in the industry if seen from the beginning of the review period.
Topics Covered in the Report

• Portugal construction Industry Research Report
• Portugal Residential Construction market
• Portugal Construction Industry Competition
• Portugal Infrastructure Industry Trends
• Portugal Residential Construction Sector Trends
• Residential Construction Market Future Outlook
• Single-Family Housing Construction Market Portugal
• Portugal construction Industry trends
• Portugal construction Industry growth
• Portugal construction Industry future
• Portugal construction Industry research
• Portugal construction Industry analysis
• Portugal construction Industry,

For more coverage click on the link below:
https://www.kenresearch.com/manufacturing-and-construction/infrastructure/residential-construction-portugal/80501-97.html
Related links:
https://www.kenresearch.com/manufacturing-and-construction/real-estate/residential-construction-tunisia/12924-97.html
https://www.kenresearch.com/manufacturing-and-construction/real-estate/residential-construction-russia/12945-97.html
Contact:
Ken Research
Ankur Gupta,
Head Marketing & Communications
query@kenresearch.com
+91-124- 4230204
www.kenresearch.com

Increase in ICT investment in Financial market to provide lucrative momentum for tech vendors: Ken Research

Ken research announced its recent publication on “ICT investment trends in financial markets”. The report provides a comprehensive on the ICT investment in financial markets. It gives an in depth analysis on the expected change in ICT budget in the upcoming years, allocation across core elements of budget and distribution of ICT investment in areas such as  cloud computing, business intelligence, and network services. The report further delineates about the distribution of financial market institution’s IT budget, factors influencing them and their investment priorities. It also gives a better understanding of financial market institutions' preferred buying approaches and their Business and IT objectives that they want to achieve through their IT investment strategies

ICT investment is the acquisition of equipment and computer software that is used in production for more than one year. ICT has three components: information technology equipment (computers and related hardware), communications equipment and software. Recent ICT trends, such as enterprise mobility, cloud computing, and business analytics has influenced ICT investment because these improvements and investment in the technology has optimized the cost structure, supported revenue growth, and streamlined operations within the enterprises. A company's IT budget is affected by multiple variables, such as the state of the economy, the type of industry sector in which it operates and the financial health of the company.  ICT spending amongst large enterprises is expected to see an increase due to the steady recovery of the international economy and improving investment environment

The ICT spending is expected to remain stagnant in 2017. The ICT investors allocate their budget across the core areas of healthcare i.e.  hardware, software, IT services, communications and consulting. In hardware spend, major expense is on desktop, laptops and server that incur almost equal cost. The rest of the expense is on Networking, external storage, tablet/ mobile, security applications and printers.  The software budget allocation is divided between investment on virtualization, productivity and OS.  In the upcoming year, the investment on the cloud and hosting service is projected to see an upward movement, especially for the email hosting. The spending on the online backup and recovery is expected to remain flat and expenditure on the web hosting may drop slightly.

Due to the economic slowdown in China, the UK exit from the European Union and Trump’s coming to power, the world is in state of political and economic instability.  Thus, this is likely to impact the ICT investment framework a many say that this uncertainty has compelled them to reconsider their companies’ decision to purchase tech products and services. The IT buyers are less likely to invest in the products from the countries like Brazil, India and China. Also, the products from EU and UK are also under the scrutiny. The major concern of the investors is regarding the storage of data. Some of IT pros are worried about the difference in the privacy regulation between countries and how it will affect  how and where the data is stored .

Financial Services are one of the pillars to the functioning of our economy. However, due to shifting business paradigms of the newly digitally these industries are most susceptible to disruption. Coupled with this problem, the growing demand for ICT governance and new regulatory requirement, it is driving the industry to invest more in ICT. Financial institutions are also using ICT to design products and services that will improve their labour productivity and are efficient for their consumers. Further, the financial markets are moving towards a centralized and highly digitalized banking system .Thus, these financial institutions are increasingly turning towards relatively new ICT technology like cloud computing to keep up with the demand of the internationally connected marketplace. The global IT spending was expected to reach 500 billion dollar by 2016.

Another important factor that has contributed to the increased investment in ICT by the financial institutions is the impact of financial recession of 2008. As the economy is slowly picking up its pace, the lenders have began to realize the importance of due diligence in decision-making and hence have began to utilize ICT resources to mitigate and manage the risk.

Companies Covered

IBM, Microsoft, Amazon web services, Google, Cisco, Oracle, Informatica, EMC.

Key Factors Considered in the Report

Global ICT Industry

Global ICT market Outlook

Global Cloud Computing Trends

Mobile Phone subscribers Worldwide

ICT Market in Financial Sector

IT Investment trends

For more coverage click on the link below

https://www.kenresearch.com/banking-financial-services-and-insurance/financial-services/ict-investment-trends-financial-markets/78614-93.html

Related links

https://www.kenresearch.com/technology-and-telecom/it-and-ites/ict-investment-trends-utilities/78615-105.html

http://https//www.kenresearch.com/healthcare/general-healthcare/ict-investment-trends-healthcare/78604-91.html

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
Ankur@kenresearch.com
+91-9015378249

The scenario of the Pediatric Vaccines segment : Ken Research

India has emerged as the leading vaccine producer in the world, in terms of doses of vaccines produced, and has about ~ major vaccine manufacturing facilities across the country. Vaccines manufactured in these facilities are offered in both national and international market (over 150 countries). With over ~ million births every year, the domestic market for vaccines in India is huge. The country has been self sufficient in meeting the domestic needs, with private sector responsible for providing a large part of the supply needs. However, India lacks in coverage rate of basic vaccines.
The Indian domestic market for Universal Immunization Programme (UIP) alone is over ~ million doses. The R&D cost of UIP vaccines is minimal; however, the non-UIP vaccines involve technology licensing, R&D, infrastructure and operational costs. In addition, stringent regulatory requirements for the licensing of newer vaccines, add up to the cost.

More than ~% of all measles vaccines used globally are produced in India. Moreover, Indian firms are big suppliers to the UN agencies, accounting in between ~% and ~% of the vaccines purchased by organization every year. India has emerged as a major vaccine producer in recent times by focusing on geographical regions where vaccines are not funded by the UN or charitable organizations and strategic ties with UN and government agencies to supply vaccines at affordable prices.
The Indian pediatric market for vaccines has grown at a remarkable CAGR of ~% during the period FY’2011-FY’2016.
The growth was attributed to some crucial vaccines (polio, hepatitis B, MMR and BCG) manufactured by Indian companies constantly featured in WHO’s prequalified list coupled with the fact that Indian companies (Serum Institute of India, Bharat Biotech, Panacea Biotec) acted as major suppliers of vaccines to WHO, UNICEF, PATH and other UN agencies. The market for pediatric vaccines grew from INR ~ billion in FY’2011 to INR ~ billion in FY’2016.
Monovalent vaccines are meant to immunize against a single antigen or a single microorganism. A fact that large chunk of vaccines administered under the national immunization programme in the country are of the monovalent form, is the major factor which has resulted in high revenue contribution from the segment. This includes monovalent oral polio vaccine, BCG, measles, Hepatitis B and Hib. Some other commonly used monovalent vaccines include rotavirus vaccine and TT.
Topics Covered in the Report

• Vaccines Market Growth India,
• Drug Pipeline Pediatric ,
• Pediatric tuberculosis drug Market,
• Number of Pediatrician  Statistics,
• Drug Information Dosage Side Effects,
• Pediatric Vaccine Serum Institute of India,
• New Drug Launches India Pharma Sector,

For more information about the publication, refer to below link:
https://www.kenresearch.com/healthcare/pharmaceuticals/india-pediatric-drug-vaccine-market/81319-91.html
Related Reports:
Global Glaucoma Treatment Drugs Market Forecast to 2020 - New Product Launches Expected to Boost Market
US Aesthetic Lasers and Energy Devices Market Outlook to 2020 - Aging Population and High Prevalence Rate of Obesity to Foster Future Growth
Qatar Wellness Market Outlook to 2020 - Rising Awareness about health & Fitness and Prevalence in Lifestyle Diseases will drive the Market
Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
Ankur@kenresearch.com
+91-9015378249

Cervical Cancer Screening Market & Patients-North America: Ken Research

Ken research announced recent publication on, "Canada, United States Cervical Cancer Screening Market & Patients, By Test Type (Pap Smear HPV DNA VIA) in North America". This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by team of industry experts. Primary sources include industry surveys and telephone interviews with industry experts. Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 1000 paid databases. It provides a comprehensive analysis and forecast till 2020. This report provides a complete analysis of 2 Countries Cervical Cancer Test Market & Number of Cervical Cancer Population. Studied countries in the report have been studied from 3 viewpoints.

• Cervical cancer Test Population (2008-2020) Pap smear test population (HPV DNA test population 2008-2020)
• Cervical Cancer Mortality Population (2001-2011)
• Cervical Cancer Test Market (2008-2020)

The Pap test finds changes in the cells of the cervix (the mouth of the womb) that are not normal. When a female has a Pap test, she is positioned on an exam table and a device called a speculum is gently inserted to open the vagina. The speculum allows the healthcare provider to view the cervix and upper vagina. Once the provider can see the cervix, a “broom” device or a brush/spatula combination will be used to collect the cells. Cervical cancer is one of the most common causes of cancer death for North American women. It is estimated that over 4,000 women in the United States and 400 women in Canada die from cervical cancer in 2016. However, it is also one of the most preventable types of cancer. Pap smear and HPV DNA test are two most popular testing methods to diagnose cervical cancer cases in North America. United States is the leader in North America cervical cancer test market. It holds over 90 percent testing population share alone, and is likely to maintain its position in forecasting period as well due to women getting regular Pap tests. The main risk factor for developing cervical cancer is the sexually transmitted human papilloma virus (HPV) that infects the cervix.

Other risk factors for developing cervical cancer include:

Becoming sexually active at a young age; having many sexual partners, or having a sexual partner that has had many sexual partners.

Smoking.

An immune system weakened from taking drugs following a transplant, or having a disease such as AIDS.

The use of birth control pills for a long period of time.

Giving birth to many children.

Having taken diethylstilbestrol (DES), or being the daughter of a mother who took DES.

Market Segmentation

This research report categorizes the global cervical cancer screening market on the basis of type of test, and end users.

Cervical Cancer Screening Market, by Test

• Pap tests
• HPV test/ Co-testing

Cervical Cancer Screening Market, y End User

• Hospitals
• Laboratories
• Physician’s offices and clinics

Cervical Cancer Screening Market, by Geography

• North America
• Europe
• Asia-Pacific
• RoW (Rest of the World)

Testing market is estimated to reach USD 8.5 Billion in 2020, expanding at a CAGR of 5.5% from 2016 to 2020, due to higher incidence of human papilloma virus (HPV) infections worldwide. Pap smear tests and colposcopy contributed to the largest share of the global cervical cancer diagnostic testing market, while HPV typing segment registered highest growth rate. By geography, North America dominated the overall market growth followed by Europe, while Asia Pacific region registered higher growth rate and likely continue to the same during the forecast period from 2016-2020. Browse Cervical Cancer Diagnostic Testing Market by Test Type (Cervical Biopsy, Colposcopy, Endocervical Curettage, HPV Typing, Loop electrosurgical procedure, Pap Smear Testing), and Imaging Tests for Stage Detection (Computed tomography or CAT, Magnetic resonance imaging, Positron emission tomography, Chest X-Ray) Cervical cancer is one of the most common cancers in women worldwide. Cervical cancer occurs when abnormal cells on the cervix grow out of control.

A virus called human papillomavirus or HPV causes most cervical cancer. The virus spreads through sexual contact. It is a malignant tumor of the lower most part of the uterus (womb) that can be prevented by PAP smear screening and a HPV vaccine. Cervical cancer is the fourth-most common cause of cancer and the fourth-most common cause of deaths from cancer in women. Two major types of cervical cancers that are typically screened and diagnosed in women include adenocarcinoma and squamous cell carcinoma. The Pap test is a screening test, not a diagnostic test, while other tests include colposcopy (with biopsy), endocervical scraping, and cone biopsies. Imaging tests such as X-rays, CT scans, magnetic resonance imaging (MRI) and positron emission tomography (PET) help determine the spread of cancer.

PAP test is the largest segment of the global market. However, HPV/co-test will be the fastest-growing product segment during the forecast period. This report segments the global cervical cancer screening market by test, and end user. Based on type of test, the global market is segmented into PAP test, and HPV test/co-testing. Based on end users, the global cervical cancer diagnosis market is categorized into hospitals, laboratories, and physician’s offices and clinics. Laboratories segment is the major end users of the global market in 2014. 

Major players operating in the global cervical cancer diagnostic testing market and included in this report are Abbott Laboratories, Becton, Dickinson and Company, Hologic, Inc., F. Hoffmann-La Roche Ltd., Quest Diagnostics, Inc., QIAGEN N.V., Femasys, Inc., Zilico Ltd., Guided Therapeutics, Inc., and OncoHealth Corp. Growth of this market is driven by growth in aging female population and rising prevalence rate of cervical cancer, high incidence rate of HPV infections, increasing number of awareness programs for cervical cancer diagnostic, and government initiatives and funding. Breakthrough products and technologies, and significant growth in the HPV test market provide new growth opportunities to players in the global market. However, Changes in regulatory guidelines for cervical cancer screening, and use of HPV vaccines are the key factors that are limiting growth of this market.  In addition, uncertain reimbursement scenario is the key market challenge.

Key Factors Considered in the Report

North America Cervical Cancer Market

North America Cervical Cancer Test Market And Forecast

North America Cervical Cancer Pap Smear Test Market

North America Cervical Cancer Hpv Dna Test Market

North America Cervical Cancer Test Market Share

North America Cervical Cancer Hpv Dna Test Market

United States Cervical Cancer Test Market

Us Cervical Cancer Pap Smear Test Future Outlook

Global Cervical Cancer Market Research

For more coverage click on the link below: 
https://www.kenresearch.com/healthcare/pharmaceuticals/canada-united-states-cervical-cancer/81992-91.html

 Related links:
https://www.kenresearch.com/healthcare/pharmaceuticals/japan-proton-therapy-market-forecast/81991-91.html

https://www.kenresearch.com/healthcare/pharmaceuticals/europe-cervical-cancer-test-market-patients/81990-91.html

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
Ankur@kenresearch.com
+91-9015378249

Presence of Foreign Insurers Uplifting Singapore Reinsurance Sector: Ken Research

Ken research announced its recent publication on "Reinsurance in Singapore, Key Trends and Opportunities to 2020" .The report provides a comprehensive analysis on the reinsurance market of Singapore. It  delineates about the competitive landscape in the country, gives a thorough overview of the Singaporean economy and demographic. It further provides detailed analysis of natural hazards and their impact on the Singaporean insurance industry.

The strength of this economy lies in its stable political and sound economic system. The nation is known for its excellent business environment and banking sector. Singapore has emerged as a high income country that is major trading regional and global hub for financial and trading services. Thus, this nation has become one of the very few nation ,which has current account surplus, ample foreign reserves and very low public external debt. However, on the other hand Singapore is highly dependent on exports, has a quite volatile.
Singapore has the most open insurance sector in the world and is fully open to foreign insurers. The MAS (monetary authority of Singapore) regulate the insurance market. This industry is currently in its boom phase as the investment and returns have been growing leaps and bounds. The introduction of FAIR ( Financial Advisory Industry Review) which has brought more transparency in production and sales . The MAS has also recommended  direct purchasing of the insurance product to combat rising operating cost and help to attract and retain talent. This move has drawn some flak from people citing that the nation is not ready for such a thing as yet but many insurance companies has supported this thought.    The insurers are licensed and  governed under the Insurance Act (Cap. 142) ("IA").Insurers can carry their business in Singapore as licensed insurers or foreign insurers. Licensed insurers can carry on direct life and/or general business, life and/or general reinsurance business or captive insurance. Foreign insurers operate in Singapore under a foreign insurer scheme established under Part IIA of the act  There are two foreign insurer designs- The Lloyd's Scheme and the Lloyd’s Asia Scheme.
Singapore is known as the reinsurance hub. Among the top 25 reinsurance companies in the world, 16 have their regional hub Singapore . with the increase in the natural catastrophes around the Asia- pacific region and Oceania, are forcing the insurance companies to share their revenues with the reinsurance companies. This has emerged as one the major reasons for the increase in the business in the reinsurance companies situated in Singapore. The multinational companies rule this market.
Authorized reinsurers and Approved Marine, Aviation and Transit ("MAT") insurers do not need to have a physical presence in Singapore. Such reinsurers can carry on the business of providing the reinsurance of liabilities under insurance policies in Singapore. They further may be authorised as general reinsurers and/or life reinsurers. MAT insurers do not write insurance business, other than the collection or receipt of premiums in relation to MAT insurance business.
Topics Covered in the Report

• Global insurance industry research
• Singapore Insurance Sector
• Singapore Life Insurance Market
• Singapore Non Life Insurance Market
• Singapore Re- Insurance Industry Future
• Singapore Reinsurance Industry Trends
• Singapore reinsurance Sector Regulations
• Singapore reinsurance gross Written Premium
• Global Reinsurance Industry
• Singapore Reinsurance Sector
• Reinsurance Market Research Singapore
• Singapore Reinsurance Sector Major players
• Singapore Reinsurance Industry size
• Singapore Reinsurance Industry growth
• Singapore Reinsurance Industry future
• Singapore Reinsurance Industry analysis

For more coverage click on the link below
https://www.kenresearch.com/banking-financial-services-and-insurance/insurance/reinsurance-singapore/74586-93.html
Related links
https://www.kenresearch.com/banking-financial-services-and-insurance/insurance/non-life-insurance-singapore/74584-93.html
https://www.kenresearch.com/banking-financial-services-and-insurance/insurance/personal-accident-health-insurance-singapore/74585-93.html
https://www.kenresearch.com/banking-financial-services-and-insurance/insurance/life-insurance-singapore/80113-93.html
Contact:
Ken Research
Ankur Gupta, Head Marketing & Communications
queranalyseearch.com
+91-124-4230204
www.kenresearch.com

Stringent Regulations in the US Pharmaceutical and Medical Devices Market: Ken Research

Ken research announced recent publication on, "Country Focus: Healthcare, Regulatory and Reimbursement Landscape in US". The report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in the US. It identifies the key trends in the country's healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by team of industry experts. Profiles and SWOT analyses of the major players in the pharmaceutical market gives exceptional market view. The effective sales and marketing strategies can be understood by understanding the competitive landscape and analysing competitors' performance help gain competitive advantage. It is a very useful tool to organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership

HEALTHCARE LANDSCAPE:

The population of the US in 2015 was 326 million, having grown at a CAGR of 1% from 2008. In 2015, the government spent 17.5% of GDP in 2015 on medical and health science and exported USD 32.8 billion of pharmaceutical products. These positive growth trends can be primarily attributed to

• Availability of latest drugs and technologies
• Universal health coverage
• Access to healthcare facilities

Major players in the medical device market include Johnson and Johnson, GE Healthcare, Siemens, Medtronic, and Philips Healthcare. Health care in the United States is provided by many distinct organizations. Health care facilities are largely owned and operated by private sector businesses. 58% of US community hospitals are non-profit, 21% are government owned, and 21% are for-profit. According to the World Health Organization (WHO), the United States spent more on health care per capita, and more on health care as percentage of its GDP, than any other nation in 2011. Health spending was paid for by the government in 2013, funded via programs such as Medicare, Medicaid, the Children's Health Insurance Program, and the Veterans Health Administration. People aged under 67 acquire insurance via their or a family member's employer, by purchasing health insurance on their own, or are uninsured. Health insurance for public sector employees is primarily provided by the government In the U.S. Ownership of the health care system is mainly in private hands, though federal, state, county, and city governments also own certain facilities.

The non-profit hospitals share of total hospital capacity has remained relatively stable for decades. There are also privately owned for-profit hospitals as well as government hospitals in some locations, mainly owned by county and city governments. The Hill-Burton Act was passed in 1946, which provided federal funding for hospitals in exchange for treating poor patients.

REGULATORY AND LICENSING LANDSCAPE:

Healthcare is subject to extensive regulation at both the federal and the state level, much of which "arose haphazardly". Under this system, the federal government cedes primary responsibility to the states under the McCarran-Ferguson Act. Essential regulation includes the licensure of health care providers at the state level and the testing and approval of pharmaceuticals and medical devices by the U.S. Food and Drug Administration (FDA), and laboratory testing. These regulations are designed to protect consumers from ineffective or fraudulent healthcare. Additionally, states regulate the health insurance market and they often have laws which require that health insurance companies cover certain procedures although state mandates generally do not apply to the self-funded health care plans offered by large employers, which exempt from state laws under pre-emption clause of the Employee Retirement Income Security Act.

 In 2010, the Patient Protection and Affordable Care Act (PPACA) was passed by President Barack Obama and includes various new regulations, with one of the most notable being a health insurance mandate which requires all citizens to purchase health insurance. While not regulation per se, the federal government also has a major influence on the healthcare market through its payments to providers under Medicare and Medicaid, which in some cases are used as a reference point in the negotiations between medical providers and insurance companies. State governments maintain state health departments, and local governments (counties and municipalities) often have their own health departments, usually branches of the state health department. Regulations of a state board may have executive and police strength to enforce state health laws. In some states, all members of state boards must be health care professionals. Members of state boards may be assigned by the governor or elected by the state committee The McCarran–Ferguson Act, which cedes regulation to the states, does not itself regulate insurance, nor does it mandate that states regulate insurance. "Acts of Congress" that do not expressly purport to regulate the "business of insurance" will not preempt state laws or regulations that regulate the "business of insurance." The Act also provides that federal anti-trust laws will not apply to the "business of insurance" as long as the state regulates in that area, but federal anti-trust laws will apply in cases of boycott, coercion, and intimidation.

REIMBURSEMENT LANDSCAPE

The healthcare reimbursement system is an extremely multifaceted framework of obtaining payment for services. One of the most problematic issues is that the “rules” governing healthcare reimbursement change frequently, with government payers sometimes changing on a day-to-day basis. n addition, the price for the service is not the “retail” price that the provider charges for it. Payers have a “maximum allowed payment” for every CPT code, which is the beginning point (not the end point) of determining what they will pay. The payer then adjusts the maximum allowed payment with “claim edits,” which they use to disqualify payment for some services, and “payment rules,” which usually reduce payments for some services. The American Medical Association (AMA) describes how payments are affected by these two rules.

Key Factors Considered in the Report

US Healthcare Industry Research

US Pharmaceutical Industry Research

Pharmaceutical Market Revenue US

US Pharmaceutical Market Imports

Export Volume Of Pharmaceutical Products US

US Medical Devices Market Research

Healthcare IT Market Research US

US Cardiovascular Device Market Future Outlook

US Orthopedic Devices Market

For more coverage click on the link below:

https://www.kenresearch.com/healthcare/pharmaceuticals/countryfocus-healthcare-regulatory-us/80510-91.html

Related links:

https://www.kenresearch.com/healthcare/pharmaceuticals/canada-united-states-cervical-cancer/81992-91.html

https://www.kenresearch.com/healthcare/pharmaceuticals/japan-proton-therapy-market-forecast/81991-91.html

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
Ankur@kenresearch.com
+91-9015378249

Demand for data increases in Myanmar leads to expansion in 3G & 4G network : Ken Research

Ken Research announced the recent production on “Myanmar: 4G Investment and new market entrants to boost burgeoning telecoms market,” which offers insights on overview of the telecommunications market in Myanmar, with detailed forecasts of key indicators up to 2021. The production provides detailed analysis of the near-term opportunities, competitive dynamics and evolution of demand by service type and technology/platform across the fixed telephony, broadband, and mobile, as well as a review of key regulatory trends. Moreover, the report offers the shrewd investigation of the economic, demographic and political aspects in Myanmar along with it a review of the regulatory setting and agenda for the next 18-24 months as well as relevant developments pertaining to spectrum licensing, national broadband plans, number portability and more. In addition, the near-term opportunities for operators, vendors and investors in Myanmar's telecommunications markets are discussed.

Competition on the rise
Myanmar’s telecoms market remains relatively young; the novel incumbent nonetheless faces an increasingly competitive environment, with the two international service providers still striving to close the gap. The state-owned entity’s subscriber base has remained largely static since mid-2015, when it counted around 18m subscribers. Telenor, however, looks to be gaining ground, having added 1.9m customers to its base in the last three months of 2015. This brings its total to almost 14m, up from 3.4m at year-end 2014.
Mobile penetration reached 63% in early 2016, up from 54.6% in late March 2015, but still well below the levels found in many other markets in the region.
For their part, existing mobile operators have expressed fears that a new player could be given some competitive advantages, such as lower licence fees or more relaxed terms for the rollout of services – which could grant the new entrant a bigger slice of the more lucrative urban market.
Potential for growth
All the while, operators continued to invest in their networks in a bid to enhance coverage and services, with enhancements to data, in specific, being given priority.
In March, Ooredoo announced plans to spend $350m in 2016 on elevating download speeds and network reach, having channelled a similar level of capital into improving its operations last year. The eventual launch of 4G services should stimulate further expansion, with increased take-up of smartphones playing a pivotal role in heightening demand.
The major move, the government pledged in November to release the necessary spectrum once service providers are ready to launch their next-generation networks. This was followed by an announcement in February that the MCIT plans to hold auctions for additional spectrum to accommodate greater data usage.
Topics Covered in the Report

• Major telecommunications Industry Research,
• Myanmar telecom industry Developments,
• Major telecommunications Sector policy,
• Myanmar telecom Players Market Share,
• Myanmar smartphones penetration Market,
• Myanmar Fixed-line penetration Market,
• Myanmar telecommunications market Opportunities
• Myanmar telecommunications market size
• Myanmar telecommunications market trends
• Myanmar telecommunications marketn growth
• Myanmar telecommunications market share
• Myanmar telecommunications market future
• Myanmar telecommunications market analysis
• Myanmar telecommunications market research
• Myanmar telecommunications market

To know more on the coverage, tap on the link underneath:
https://www.kenresearch.com/technology-and-telecom/telecommunications-and-networking/myanmar-4g-investment-new-market-entrants-boost/78616-105.html
Related Links
https://www.kenresearch.com/technology-and-telecom/telecommunications-and-networking/philippines-mobile-data-digital-services-are-key-drivers/78617-105.html
https://www.kenresearch.com/technology-and-telecom/telecommunications-and-networking/singapore-embracing-smart-nation-telco-media/78618-105.html
Contact:
Ken Research
Ankur Gupta, Head Marketing & Communications
query@kenresearch.com
+91-124-4230204